Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biotechnology Index Fund FBJ jumped 4% by the afternoon, while the Defiance Nasdaq Junior Biotechnology ETF IBBJ, -1.01% and the SPDR S&P Biotech ETF XBI, -0.01% both gained 3.5%. The VanEck Vectors Biotech ETF BBJ, gained 2.7%, and the Global X Genomics & Biotechnology ETF GNOM, +1.29% was 2.3% higher on Monday but has gained the most - 56% - in the year to date among the funds noted here. FactSet data show that among all U.S. domiciled ETFs, the Van Eck fund has the most exposure to Alexion